The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: doxorubicin hydrochloride     Quarter: 2016Q3

Total Records: 406     Number of Pages: 21

DRUGNAME PT EventCount
DOXORUBICIN HYDROCHLORIDE. Myopathy 3
DOXORUBICIN HYDROCHLORIDE. Oedema peripheral 3
DOXORUBICIN HYDROCHLORIDE. Pericardial effusion 3
DOXORUBICIN HYDROCHLORIDE. Pleural effusion 3
DOXORUBICIN HYDROCHLORIDE. Pneumocystis jirovecii pneumonia 3
DOXORUBICIN HYDROCHLORIDE. Posterior reversible encephalopathy syndrome 3
DOXORUBICIN HYDROCHLORIDE. Pulse absent 3
DOXORUBICIN HYDROCHLORIDE. Respiratory distress 3
DOXORUBICIN HYDROCHLORIDE. Tumour lysis syndrome 3
Doxorubicin Hydrochloride (Actavis Inc) Febrile neutropenia 2
DOXORUBICIN HYDROCHLORIDE. Abortion spontaneous 2
DOXORUBICIN HYDROCHLORIDE. Acute left ventricular failure 2
DOXORUBICIN HYDROCHLORIDE. Acute myeloid leukaemia 2
DOXORUBICIN HYDROCHLORIDE. Amyloidosis 2
DOXORUBICIN HYDROCHLORIDE. Blood fibrinogen decreased 2
DOXORUBICIN HYDROCHLORIDE. Bone disorder 2
DOXORUBICIN HYDROCHLORIDE. Bone infarction 2
DOXORUBICIN HYDROCHLORIDE. Bone pain 2
DOXORUBICIN HYDROCHLORIDE. Cardio-respiratory arrest 2
DOXORUBICIN HYDROCHLORIDE. Cardiovascular disorder 2

Total Records: 406     Number of Pages: 21